Business

Exploring the intersection of finance, pharma, and biotech

Special Report Bob Herman, Kate Sheridan, J. Emory Parker, Adam Feuerstein and Mohana Ravindranath

Health care’s high rollers: As the pandemic raged, CEOs’ earnings surged

Health care’s top executives are cushioned more than ever by the rising fortunes of their stock ownership.

Read The Story

Insurance Bob Herman

Many Blue Cross Blue Shield plans aren’t paying taxes — and instead are swimming in refunds

Health Olivia Goldhill

‘It’s not medical’: Oregon wrestles with how to offer psychedelics outside the health care system

Business Allison Bond

A ‘Shark Tank’-funded test for food sensitivity is medically dubious, experts say

Business Rebecca Robbins

Anxious about a big speech? This startup wants to calm you down — with a cardiac drug you pop like a mint

All Coverage

Business Bob Herman

Biotech employees cash in health care’s largest salaries, while people working at providers sit near the bottom

Hospitals Bob Herman

HCA, Steward abandon hospital deal in another win for FTC

Hospitals Bob Herman

New Jersey hospitals scrap merger after FTC challenge

Business Bob Herman

Real estate firms own nearly 1 in 10 health care properties

Business Tara Bannow and Bob Herman

Omicron squeezed hospitals more than health insurers in the first quarter

Biotech Allison DeAngelis

Despite biotech slump, veterans of SVB and KKR launch investment firm

Business Bob Herman

The doctor who is trying to bring back surprise billing

Business Andrew Joseph

‘We are not casting a wide enough net’: Rob Perez on how biopharma companies can help out their neighbors

Business Tara Bannow

A hospital lobbying juggernaut makes an unlikely pivot into venture capital

Business Bob Herman

TeamHealth hit with another lawsuit for alleged overbilling, this time from an employer

Business Bob Herman

The biggest PBMs are handling more and more of the country’s drug price negotiations

Business Bob Herman

Patients are flocking back to hospitals, but volumes are at the mercy of Covid surges, new documents show

Business Bob Herman

A glaring gap in Congress’ surprise billing law leaves patients on the hook for pricey, out-of-network lab tests

Business Bob Herman

Even as it struggles, startup insurer Bright Health deepens its ties to Cigna

Business Rachel Cohrs

Private equity firms are cashing in on the travel nursing business that has boomed during the pandemic

Exclusive Rachel Cohrs

The Catholic hospital system Ascension is running a Wall Street-style private equity fund

A STAT Investigation Rachel Cohrs

How America’s largest Catholic hospital system is moonlighting as a private equity firm

Pharma Olivia Goldhill

Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property

A STAT Investigation Eric Boodman

Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?

Jonathan Saltzman — Boston Globe

Lawyers for Henrietta Lacks estate say more companies to be sued over use of her cells

Business Andrew Joseph

Third member of FDA expert committee resigns over controversial Alzheimer’s therapy decision

Business Andrew Joseph

Member of FDA’s expert panel resigns over controversial Alzheimer’s therapy approval

Exclusive Adam Feuerstein and Damian Garde

Martin Shkreli’s longtime friend wants to undo his 4,000% price hike. But first he’ll have to finally oust the ‘pharma bro’

Business Alicia Diaz

Business

Health care’s high rollers: As the pandemic raged, CEOs’ earnings surged

Many Blue Cross Blue Shield plans aren’t paying taxes — and instead are swimming in refunds

‘It’s not medical’: Oregon wrestles with how to offer psychedelics outside the health care system

A ‘Shark Tank’-funded test for food sensitivity is medically dubious, experts say

Anxious about a big speech? This startup wants to calm you down — with a cardiac drug you pop like a mint

All Coverage

Biotech employees cash in health care’s largest salaries, while people working at providers sit near the bottom

HCA, Steward abandon hospital deal in another win for FTC

New Jersey hospitals scrap merger after FTC challenge

Real estate firms own nearly 1 in 10 health care properties

Omicron squeezed hospitals more than health insurers in the first quarter

Despite biotech slump, veterans of SVB and KKR launch investment firm

The doctor who is trying to bring back surprise billing

‘We are not casting a wide enough net’: Rob Perez on how biopharma companies can help out their neighbors

A hospital lobbying juggernaut makes an unlikely pivot into venture capital

TeamHealth hit with another lawsuit for alleged overbilling, this time from an employer

The biggest PBMs are handling more and more of the country’s drug price negotiations

Patients are flocking back to hospitals, but volumes are at the mercy of Covid surges, new documents show

A glaring gap in Congress’ surprise billing law leaves patients on the hook for pricey, out-of-network lab tests

Even as it struggles, startup insurer Bright Health deepens its ties to Cigna

Private equity firms are cashing in on the travel nursing business that has boomed during the pandemic

The Catholic hospital system Ascension is running a Wall Street-style private equity fund

How America’s largest Catholic hospital system is moonlighting as a private equity firm

Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property

Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?

Lawyers for Henrietta Lacks estate say more companies to be sued over use of her cells

Third member of FDA expert committee resigns over controversial Alzheimer’s therapy decision

Member of FDA’s expert panel resigns over controversial Alzheimer’s therapy approval

Martin Shkreli’s longtime friend wants to undo his 4,000% price hike. But first he’ll have to finally oust the ‘pharma bro’

Medical device firms’ payments to doctors far outstripped those from pharma, study shows

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day